✦ LIBER ✦

PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United Kingdom

✍ Scribed by Jiang, Y.; Spencer, M.; Gauthier, A.; Pacou, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN65 A COST-EFFECTIVENESS ANALYSIS OF T

✍ KK Lee; VW Lee; KC Kuok 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PSY4 Lenalidomide or Bortezomib for the

✍ Kaura, S.; Dranitsaris, G. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN46 A COST UTILITY ANALYSIS OF MAINTEN

✍ U Geary; G Lewis; R Aultman; M Aristides 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCN24 PEGYLATED LIPOSOMAL DOXORUBICIN IN

✍ CJ Gibbons; K Yong; G Roberts 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost effectiveness of treatments for rel

✍ Jack Ishak; Filipe Rodrigues 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB